CClinicalTrials.gg
Not yet recruitingNCT05462691Updated Jul 18, 2022

"Suture of the Tuberosities in Inverted Prostheses" Implanted for Acute Fractures of the Proximal Humerus?.

An interventional study of tuberosity suture in Proximal Humeral Fractures, Reverse Shoulder Prostheses, Tuberosities, sponsored by Hospital del Mar. Not yet recruiting. Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2022-07-18.

Sponsored by Hospital del Mar · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

Complex fractures of the proximal humerus in elderly patients constitute a growing problem. Osteoporosis linked to these fractures prevents osteosynthesis correctly, so that if the offset between the fragments is large, it is necessary to implant a prosthesis. Inverted prostheses, normally used for the treatment of osteoarthritis with absence of the rotator cuff, have become the treatment of choice in these fractures obtaining very favorable results. Traditionally, once the prosthesis is implanted, they are sutured the tuberosities with the rotator cuff tendons to the prosthesis. This gesture is supposed to will improve patient function. However, this prosthesis was originally designed for use in patients without a rotator cuff, so the need for this suture, which lengthens surgical time and requires an increase in the number of sutures, which can potentially increase the risk of infection. With the results of this study, it would be possible to reduce the surgical time, the number of inert materials implanted, and potentially the risk of infection.

Read the detailed description

Complex fractures of the proximal humerus in elderly patients constitute a growing problem. Osteoporosis linked to these fractures prevents osteosynthesis correctly, so that if the offset between the fragments is large, it is necessary to implant a prosthesis. Inverted prostheses, normally used for the treatment of osteoarthritis with absence of the rotator cuff, have become the treatment of choice in these fractures obtaining very favorable results. Traditionally, once the prosthesis is implanted, they are sutured the tuberosities with the rotator cuff tendons to the prosthesis. This gesture is supposed to will improve patient function. However, this prosthesis was originally designed for use in patients without a rotator cuff, so the need for this suture, which lengthens surgical time and requires an increase in the number of sutures, which can potentially increase the risk of infection. With the results of this study, it would be possible to reduce the surgical time, the number of inert materials implanted, and potentially the risk of infection.

Primary objective:

To determine if there are differences in the perception of quality of life measured by through the Simple Shoulder Test scale, among the patients in whom sutured the tuberosities and patients who have had the tuberosities excised tuberosities.

Secondary objectives:

To determine if there are differences between the patients in whom suturing has been the tuberosities and patients who have had their tuberosities excised about:

  • SPADI quality of life test.
  • Constant functional test.
  • number of prosthetic dislocations
  • Percentage of scapular notch development measured according to the Sirveaux scale.
  • Number of dislocations.
  • number of infections.
  • number of revision surgeries.
02

Conditions studied

  • Proximal Humeral Fractures, Reverse Shoulder Prostheses, Tuberosities
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 90 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Hospital del Mar is the lead sponsor of 45 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients > 65 yrs. and \< 85 yrs.
  • Acute fracture of the proximal humerus.
  • implantation of inverted shoulder prosthesis.

Exclusion criteria

Exclusion Criteria:

  • acute fractures of more than 3 weeks of evolution
  • Associated fractures.
  • senile dementia and/or cognitive alterations that prevent compliance protocols
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Patients without tuberosity reconstruction

    patients undergoing reverse shoulder arthroplasty because a proximal humeral fracture with suturing of the tuberosities

    Procedure: tuberosity suture

  • Active comparator
    Patients with tuberosity reconstruction

    patients undergoing reverse shoulder arthroplasty because a proximal humeral fracture without suturing of the tuberosities

    Procedure: tuberosity suture

Interventions

  • Proceduretuberosity suture

    to suture or not suture the tuberosities in reverse shoulder arthroplasty because of a proximal humeral fracture

06

What researchers measure

Primary outcomes

  1. Simple Shoulder Test

    Primary objective: To determine if there are differences in the perception of quality of life measured by through the Simple Shoulder Test scale, among the patients in whom sutured the tuberosities and patients who have had the tuberosities excised tuberosities.

    Time frame: 24 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05462691
Lead sponsor
Hospital del Mar
Responsible party
Carlos Torrens (Clinical Professor, Hospital del Mar) — Principal investigator
First posted
Jul 18, 2022
Start date
Sep 1, 2022 (estimated)
Primary completion
Sep 1, 2023 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
Jul 18, 2022

Study contacts

Carlos Torrens, MD
Contact
CTorrens@psmar.cat
003493674100 ext. 4201

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion